Subscribe to RSS
Challenges in Diagnosing Rare Genetic Causes of Common In Utero Presentations: Report of Two Patients with Mucolipidosis Type II (I-Cell Disease)
09 January 2018
05 February 2018
09 March 2018 (online)
Traditional approaches to prenatal genetic diagnosis for common presentations such as short femurs or intrauterine growth restriction are imperfect, and whole-exome sequencing is an emerging option. Mucolipidosis type II (I-cell disease) is an ultra-rare autosomal recessive lysosomal storage disorder with the potential for prenatal-onset skeletal and placental manifestations. We describe the prenatal signs in two recent unrelated patients with confirmed diagnoses soon after birth. In both cases, parents were consanguineous but there was no known family history of mucolipidosis type II. False reassurance was provided after negative testing for another disease with overlapping prenatal manifestations already present in one of the families, emphasizing that offspring of consanguineous parents can be at risk for more than one recessive condition. Our experience illustrates the potential advantages in expanding prenatal applications of WES for the identification of rare single gene disorders in offspring of consanguineous unions.
Keywordslysosomal storage disease - mucolipidosis - prenatal diagnosis - genetic testing - skeletal dysplasia
Both families provided informed consent for inclusion in this report. Approval from a Research Ethics Board is not required at our institution for publication of a case series.
* These authors contributed equally.
- 1 Best S, Wou K, Vora N, Van der Veyver IB, Wapner R, Chitty LS. Promises, pitfalls and practicalities of prenatal whole exome sequencing. Prenat Diagn 2018; 38 (01) 10-19
- 2 Leroy JG, Cathey S, Friez MJ, Mucolipidosis II. 2008 Aug 26 [Updated 2012 May 10]. In: Adam MP, Ardinger HH, Pagon RA. , et al., eds. GeneReviews® [Internet]. Seattle, WA: University of Washington, Seattle; 1993–2018. Available at: https://www.ncbi.nlm.nih.gov/books/NBK1828/
- 3 Plante M, Claveau S, Lepage P. , et al. Mucolipidosis II: a single causal mutation in the N-acetylglucosamine-1-phosphotransferase gene (GNPTAB) in a French Canadian founder population. Clin Genet 2008; 73 (03) 236-244
- 4 Kudo M, Brem MS, Canfield WM. Mucolipidosis II (I-cell disease) and mucolipidosis IIIA (classical pseudo-hurler polydystrophy) are caused by mutations in the GlcNAc-phosphotransferase alpha / beta -subunits precursor gene. Am J Hum Genet 2006; 78 (03) 451-463
- 5 Lai LM, Lachman RS. Early characteristic radiographic changes in mucolipidosis II. Pediatr Radiol 2016; 46 (12) 1713-1720
- 6 Unger S, Paul DA, Nino MC. , et al. Mucolipidosis II presenting as severe neonatal hyperparathyroidism. Eur J Pediatr 2005; 164 (04) 236-243
- 7 Lees C, Homfray T, Nicolaides KH. Prenatal ultrasound diagnosis of Leroy I cell disease. Ultrasound Obstet Gynecol 2001; 18 (03) 275-276
- 8 Rapola J, Aula P. Morphology of the placenta in fetal I-cell disease. Clin Genet 1977; 11 (02) 107-113
- 9 Saul RA, Proud V, Taylor HA, Leroy JG, Spranger J. Prenatal mucolipidosis type II (I-cell disease) can present as Pacman dysplasia. Am J Med Genet A 2005; 135 (03) 328-332
- 10 Yuksel A, Kayserili H, Gungor F. Short femurs detected at 25 and 31 weeks of gestation diagnosed as Leroy I-cell disease in the postnatal period: a report of two cases. Fetal Diagn Ther 2007; 22 (03) 198-202
- 11 Hadlock FP, Harrist RB, Carpenter RJ. , et al. Sonographic estimation of fetal weight. The value of femur length in addition to head and abdomen measurements. Radiology 1984; 150 (02) 535-540
- 12 Barkova E, Mohan U, Chitayat D. , et al. Fetal skeletal dysplasias in a tertiary care center: radiology, pathology, and molecular analysis of 112 cases. Clin Genet 2015; 87 (04) 330-337
- 13 Fowler DJ, Anderson G, Vellodi A, Malone M, Sebire NJ. Electron microscopy of chorionic villus samples for prenatal diagnosis of lysosomal storage disorders. Ultrastruct Pathol 2007; 31 (01) 15-21